The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donoso, L. A.
Right arrow Articles by Fong, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donoso, L. A.
Right arrow Articles by Fong, S. L.

The Journal of Immunology, Vol 143, Issue 1 79-83, Copyright © 1989 by American Association of Immunologists


ARTICLES

Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis

LA Donoso, CF Merryman, T Sery, R Sanders, T Vrabec and SL Fong
Retina Service, Wills Eye Hospital, Philadelphia, PA 19107.

Human interstitial retinoid binding protein (HIRBP) is a 136,000 m.w. photoreceptor cell protein which transports retinoids between the retina and the retinal pigment epithelium of the eye. The amino acid sequence of HIRBP suggests that the molecule consists of four continuous homology domains which arose by several gene duplications some 600 to 800 million years ago. When injected into susceptible animal species, including primates, it induces an experimental autoimmune uveitis (EAU), a predominantly T cell-mediated autoimmune disease of the retina and uveal tract of the eye, and the pineal gland. In order to further refine specific sites in HIRBP responsible for its uveitopathogenicity, we synthesized 120 overlapping peptide corresponding to its entire 1262 amino acid sequence, and tested each peptide for its ability to induce an EAU in Lewis rats. Five peptides with extensive amino acid sequence homology, designated HIRBP 715, HIRBP greater than 730 and HIRBP 745, HIRBP 778, and HIRBP 808 were uveitopathogenic when used at a 50 micrograms immunizing dose. The most potent peptide for the induction of EAU was HIRBP 715 (amino acid positions 521 to 540). In dose response studies as little as 0.1 microgram/animal was capable of inducing an inflammatory response. In addition, peptide HIRBP 946 which corresponds to the mid portion of peptide HIRBP 715 and contains only eight amino acids (RTATAAEE) was uveitopathogenic under our experimental conditions. Our study identifies multiple uveitopathogenic sites in HIRBP and further defines the amino acids necessary for the induction of EAU in one of these sites.


This article has been cited by other articles:


Home page
IOVSHome page
L. M. Cortes, M. J. Mattapallil, P. B. Silver, L. A. Donoso, G. I. Liou, W. Zhu, C.-C. Chan, and R. R. Caspi
Repertoire Analysis and New Pathogenic Epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1946 - 1956.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Terrada, S. Fisson, Y. De Kozak, M. Kaddouri, P. Lehoang, D. Klatzmann, B. L. Salomon, and B. Bodaghi
Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen.
J. Immunol., June 15, 2006; 176(12): 7171 - 7179.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Liao, Y. Ke, W.-H. Shao, B. Haribabu, H. J. Kaplan, D. Sun, and H. Shao
Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1543 - 1549.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. M. Z. Howard, H. F. Dong, S. B. Su, R. R. Caspi, X. Chen, P. Plotz, and J. J. Oppenheim
Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate
Blood, June 1, 2005; 105(11): 4207 - 4214.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Shao, Y. Fu, T. Liao, Y. Peng, L. Chen, H. J. Kaplan, and D. Sun
Anti-CD137 mAb Treatment Inhibits Experimental Autoimmune Uveitis by Limiting Expansion and Increasing Apoptotic Death of Uveitogenic T Cells
Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 596 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Shao, S. L. Sun, H. J. Kaplan, and D. Sun
Characterization of Rat CD8+ Uveitogenic T Cells Specific for Interphotoreceptor Retinal-Binding Protein 1177-1191
J. Immunol., August 15, 2004; 173(4): 2849 - 2854.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Avichezer, R. S. Grajewski, C.-C. Chan, M. J. Mattapallil, P. B. Silver, J. A. Raber, G. I. Liou, B. Wiggert, G. M. Lewis, L. A. Donoso, et al.
An Immunologically Privileged Retinal Antigen Elicits Tolerance: Major Role for Central Selection Mechanisms
J. Exp. Med., December 1, 2003; 198(11): 1665 - 1676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Shao, S. Lei, S. L. Sun, H. J. Kaplan, and D. Sun
Conversion of Monophasic to Recurrent Autoimmune Disease by Autoreactive T Cell Subsets
J. Immunol., November 15, 2003; 171(10): 5624 - 5630.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.